Bobby Gaspar
2020
In 2020, Bobby Gaspar earned a total compensation of $3.8M as Chief Executive Officer at Orchard Therapeutics plc, a 311% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $169,897 |
|---|---|
| Option Awards | $3,070,610 |
| Salary | $542,513 |
| Total | $3,783,020 |
Gaspar received $3.1M in option awards, accounting for 81% of the total pay in 2020.
Gaspar also received $169.9K in non-equity incentive plan and $542.5K in salary.
Rankings
In 2020, Bobby Gaspar's compensation ranked 3,042nd out of 13,090 executives tracked by ExecPay. In other words, Gaspar earned more than 76.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,042 out of 13,090 | 77th |
Division Manufacturing | 1,187 out of 5,621 | 79th |
Major group Chemicals And Allied Products | 452 out of 2,254 | 80th |
Industry group Drugs | 391 out of 1,954 | 80th |
Industry Biological Products, Except Diagnostic Substances | 98 out of 411 | 76th |
Source: SEC filing on April 28, 2021.
Gaspar's colleagues
We found two more compensation records of executives who worked with Bobby Gaspar at Orchard Therapeutics plc in 2020.